Dollar General Q3 2025 Earnings Lift Forecast

Dollar General Q3 2025 earnings drove a FY 2025 guidance raise citing traffic gains and market-share momentum that may shift trader positioning.

December 04, 2025·2 min read
View all news articles
Flat vector of a discount store shelf bulging with goods to symbolize Dollar General Q3 2025 earnings and guidance raise

KEY TAKEAWAYS

  • Q3 net sales reached $10.7 billion and diluted EPS rose to $1.28.
  • Management raised FY 2025 guidance, setting diluted EPS to $6.30-$6.50.
  • Same-store sales and store traffic each grew 2.5%, supporting market-share momentum.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Dollar General Corporation (DG) reported stronger momentum in its Q3 2025 earnings on Dec. 4, 2025, raising its full-year forecast after management cited market-share gains across consumables and non-consumables alongside rising store traffic.

Quarter Results and Guidance

The company said in a press release on Dec. 4, 2025, that net sales for the quarter ended Oct. 31 reached $10.7 billion, up 4.6% year over year. Diluted earnings per share rose 43.8% to $1.28, while net income increased by the same percentage to $283 million.

Gross profit grew 8.5% to $3.2 billion, and operating profit expanded 31.5%, reflecting margin improvement. Cost of sales rose 3.0% to $7.5 billion.

Dollar General raised its fiscal 2025 guidance, setting net sales growth to 4.7%–4.9%, same-store sales growth to 2.5%–2.7%, and diluted EPS to $6.30–$6.50. Management attributed the raise to the quarter’s strength, an improved outlook for the rest of the year, market-share gains, and positive customer traffic.

Traffic, Market Share, and Store Plans

Same-store sales grew 2.5%, marking the company’s eighth consecutive quarter of positive comps. Store traffic also rose 2.5%, while average transaction amounts remained flat year over year.

Management highlighted market-share gains in consumables such as packaged foods, cleaning products, and health and beauty items, as well as in non-consumables including apparel, home goods, and seasonal goods. Total customer counts increased, with a disproportionate rise among higher-income households.

The company reaffirmed plans to open roughly 575 new stores in fiscal 2025 and about 450 in fiscal 2026.

On the balance sheet, total liabilities declined 2.0% year over year to $23.6 billion. The company described cash flow and liquidity as stronger, citing reduced liabilities.

This quarter marked Dollar General’s fifth straight top-line beat and ninth in the past ten quarters, with its widest margin for a bottom-line beat in at least five years.

Management said the current quarter started strongly despite a delay in Supplemental Nutrition Assistance Program (SNAP) benefit payments to some core customers in early November.

Fiscal 2026 guidance and holiday-season execution will be the next key catalysts, with Q4 2025 results expected around February 2026.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Joby Aviation Acquisition Tests Financing Plans

Joby Aviation Acquisition Tests Financing Plans

Joby Aviation acquisition expands the defense footprint and files an at-the-market offering, creating a funding path while raising dilution concerns.

Lumentum Earnings Rise on AI Optical Demand

Lumentum Earnings Rise on AI Optical Demand

Lumentum earnings showed stronger Q4 results and above-range Q1 FY2027 guidance citing AI data-center optical demand, supporting bullish trader interest.

Micron Price Targets Show Wide Upside Range

Micron Price Targets Show Wide Upside Range

Micron price targets rose as AI memory demand tightened HBM supply; aggregator averages imply sizable upside while traders weigh the DRAM pricing outlook.

Spotify AI Persona Labels Limit Recommendations

Spotify AI Persona Labels Limit Recommendations

Spotify AI Persona labels will flag suspected AI artists and exclude them from recommendations by default, a product change that could shift discovery.

Capricor Therapeutics Class Action After FDA Data Concerns

Capricor Therapeutics Class Action After FDA Data Concerns

Capricor Therapeutics class action alleges misleading Deramiocel claims after FDA briefing concerns over HOPE-3, creating near-term legal and trading risk.

Curaleaf Takeover Bid for Aurora

Curaleaf Takeover Bid for Aurora

Curaleaf takeover bid for Aurora offers 0.3463 shares plus US$0.75, implying US$4.00 per share and no financing condition, prompting trader scrutiny.